Related Experiment Videos
Presenilin mutations line up along transmembrane alpha-helices
1Department of Neuroscience, Mayo Clinic, Jacksonville, FL 32224, USA. hardy@mayo.edu
Neuroscience Letters
|June 19, 2001
Summary
Pathogenic mutations in presenilin 1 (PSEN1) cause autosomal dominant Alzheimer's disease. These mutations disrupt the alignment of PSEN1 transmembrane domains, explaining their harmful effects.
Area of Science:
- Neuroscience
- Genetics
- Molecular Biology
Background:
- Presenilin 1 (PSEN1) mutations are the primary genetic cause of autosomal dominant Alzheimer's disease (ADAD).
- Understanding the structural and functional impact of these mutations is crucial for developing targeted therapies.
Purpose of the Study:
- To investigate the structural localization of pathogenic PSEN1 mutations within its transmembrane domains.
- To elucidate the mechanism by which PSEN1 mutations lead to Alzheimer's disease.
Main Methods:
- Analysis of mutation positions within the predicted transmembrane domains of the PSEN1 protein.
- Structural modeling to assess the alignment of mutated residues along helical faces.
Main Results:
- Pathogenic PSEN1 mutations were found to be located on the helical faces of transmembrane domains 1, 2, 3, 4, and 6.
- This alignment suggests that these domains are indeed transmembrane segments.
- Disruption of the normal alignment of these transmembrane domains correlates with disease pathogenicity.
Conclusions:
- The findings support the model of PSEN1 as a multi-transmembrane protein.
- The pathogenicity of PSEN1 mutations likely arises from the disruption of transmembrane domain alignment, impacting protein function and contributing to Alzheimer's disease pathogenesis.